{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T16:47:59Z","timestamp":1768150079062,"version":"3.49.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"DOI":"10.1182\/blood.2024023862","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:30:43Z","timestamp":1714663843000},"page":"1785-1786","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["ADAMTS13 recovery in caplacizumab-treated TTP"],"prefix":"10.1182","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4538-5154","authenticated-orcid":false,"given":"Bernhard","family":"L\u00e4mmle","sequence":"first","affiliation":[{"name":"University of Bern"},{"name":"University Medical Center Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"18","key":"2024050215303335600_bib1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2023022725","article-title":"ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura\u00a0after caplacizumab therapy: the Spanish Registry","volume":"143","author":"Mingot-Castellano","year":"2024","journal-title":"Blood"},{"issue":"18","key":"2024050215303335600_bib2","first-page":"2206","article-title":"Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era","volume":"141","author":"Prasannan","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2024050215303335600_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.2020008021","article-title":"A\u00a0regimen with caplacizumab, immunosuppression, and plasma exchange\u00a0prevents unfavorable outcomes in\u00a0immune-mediated TTP","volume":"137","author":"Coppo","year":"2021","journal-title":"Blood"},{"issue":"13","key":"2024050215303335600_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1182\/blood.2020007599","article-title":"Real-world experience with caplacizumab in the management of acute TTP","volume":"137","author":"Dutt","year":"2021","journal-title":"Blood"},{"issue":"3","key":"2024050215303335600_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jtha.2022.11.010","article-title":"Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura","volume":"21","author":"V\u00f6lker","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"2024050215303335600_bib6","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.jtha.2023.07.027","article-title":"Five years of caplacizumab \u2013 lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpura","volume":"21","author":"V\u00f6lker","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"2024050215303335600_bib7","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/bloodadvances.2020001834","article-title":"Caplacizumab prevents refractoriness and\u00a0mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis","volume":"5","author":"Peyvandi","year":"2021","journal-title":"Blood Adv"},{"issue":"13","key":"2024050215303335600_bib8","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/bloodadvances.2020001987","article-title":"ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP","volume":"4","author":"V\u00f6lker","year":"2020","journal-title":"Blood Adv"},{"key":"2024050215303335600_bib9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19284","article-title":"Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab","author":"Schimmer","year":"2  2024","journal-title":"Br J Haematol"},{"issue":"3","key":"2024050215303335600_bib10","first-page":"536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, management","volume":"10","author":"Sukumar","year":"2021","journal-title":"J\u00a0Clin Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/18\/1785\/2223701\/blood_bld-2024-023862-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/18\/1785\/2223701\/blood_bld-2024-023862-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:30:49Z","timestamp":1714663849000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/143\/18\/1785\/515838\/ADAMTS13-recovery-in-caplacizumab-treated-TTP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":10,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,5,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024023862","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}